Once-daily verapamil did not significantly improve C-peptide levels compared with placebo for adults with new-onset type 1 ...

An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, ...

Patients with type 1 and type 2 diabetes present similar symptoms, however, the causes are not the same. Type 1 diabetes, which is characterized by deficient insulin production, is considered to be ...

What is the role of C peptide in managing uncontrolled type 2 diabetes? —Ndukwe H. Odeluga, MD, Bakersfield, Calif. Cleaved from proinsulin to make mature insulin, C peptide can be considered a marker ...

LIVERPOOL — C-peptide testing a few years after a diagnosis of type 1 diabetes should be a routine procedure as it can help pinpoint occasional patients who have been misdiagnosed and actually have ...

SAN DIEGO – Diabetes stakeholders will meet with CMS in October to urge the agency to update its National Coverage ...

(HealthDay News) – Some patients who have had type 1 diabetes for decades can still produce C-peptide and respond to hyperglycemia, suggesting residual β-cell function, according to a study published ...

Tandem Diabetes Care® (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today announced the ...

Tandem Diabetes Care’s Control-IQ+ automated insulin delivery system can lower HbA1c’s in adults with insulin-treated Type 2 ...

A C-peptide level of more than 20 pmol/L may indicate a lower risk for hypoglycemia among adults with type 1 diabetes, suggesting that these individuals may safely pursue tighter glycemic targets, ...

The new findings come from a 15-year study examining the natural course of C-peptide in children and adolescents with type 1 diabetes (T1D). A marker of pancreatic function in patients with diabetes ...

The draft EASD/ADA Type 1 Diabetes Management Guidance document adds new information about diagnosing T1D in adults as well ...